Drugmakers beat the Street

$1.4 billion to $1.6 billion previously. Gardasil, which is facing competition from a rival product from GlaxoSmithKline PLC, was recently denied approval by U.S. regulators for use by women aged 27 to 45. Merck said its 2009 sales would be at the lower...